Hirokuni Ikeda

616 citations
44 papers · 472 · h-index 10

Impact in

    • Cancer-related Molecular Pathways
    • Cancer Cells and Metastasis
    • Cancer Treatment and Pharmacology
    • Breast Cancer Treatment Studies

Papers in

    • Gastrointestinal disorders and treatments 6
    • Pancreatitis Pathology and Treatment 3
    • Esophageal and GI Pathology 3
    • Trauma Management and Diagnosis 3
    • Metastasis and carcinoma case studies 4

Hirokuni Ikeda

33 papers receiving 455 citations

Peers

Hirokuni Ikeda
Comparison fields: 5 of 70
  • Oncology 205
  • Cancer Research 109
  • Pulmonary and Respiratory Medicine 125
  • Pathology and Forensic Medicine 62
  • Molecular Biology 195
Replace Carla Azzurra Amoreo with:
Carla Azzurra Amoreo Italy
Zhiguo Luo China
Xiaoyan Lin China
Patrick Lebok Germany
Ruizhao Qi China
Ashwini Esnakula United States
You-Hong Fan United States
Janyaporn Phuchareon United States
Qianfei Zhang United States
Tomohiro Nogami Japan
Hirokuni Ikeda relative to Carla Azzurra Amoreo Italy Carla Azzurra Amoreo's profile →
Citations per field
00.5×1.7×
Carla Azzurra Amoreo · 1×
Citations per year

Countries citing papers authored by Hirokuni Ikeda

Since Specialization
Citations

This map shows the geographic impact of Hirokuni Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirokuni Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirokuni Ikeda more than expected).

Fields of papers citing papers by Hirokuni Ikeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirokuni Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirokuni Ikeda. The network helps show where Hirokuni Ikeda may publish in the future.

Co-authors

The 25 scholars most cited alongside Hirokuni Ikeda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hirokuni Ikeda Line = papers co-authored together Hirokuni Ikeda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1 200874
2 200964
3 201855
4 201054
5 201139
6 201228
7 200824
8 201919
9 202018
10 20209
11 20158
12 20208
13
[A Case of Primary Acinic Cell Carcinoma(ACC)of the Breast].
20168
14 20037
15 20156
16 20075
17 20165
18 20135
19 20134
20 20193

About Hirokuni Ikeda

Hirokuni Ikeda is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Gastroenterology, having authored 44 papers that have together received 472 indexed citations. Recurring topics across this work include Gastrointestinal disorders and treatments (6 papers), Metastasis and carcinoma case studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Pancreatitis Pathology and Treatment (3 papers), HER2/EGFR in Cancer Research (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), Esophageal and GI Pathology (3 papers) and Trauma Management and Diagnosis (3 papers). The work is most often cited by research in Oncology (205 citations), Cancer Research (109 citations), Pulmonary and Respiratory Medicine (125 citations), Pathology and Forensic Medicine (62 citations) and Molecular Biology (195 citations). Hirokuni Ikeda has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroyoshi Doihara, Naruto Taira, Tadahiko Shien, Yutaka Ogasawara, Kensuke Kawasaki, Takeo Fujita, Mina Takahashi, Tomohiro Nogami, Shinichiro Miyoshi and Shinichi Toyooka. Their work appears in journals such as Breast Cancer, Cancer Science, Clinical Breast Cancer, BMC Cancer and Breast Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact